Wall Street Analysts Just Trimmed Price Targets for These 5 Stocks

Page 5 of 5

01. NextCure, Inc. (NASDAQ:NXTC)

Price Reaction after the Price Target Cut: -0.2800 (-19.3103%)

On December 14, Needham & Company LLC revised its target price for NextCure, Inc. (NASDAQ:NXTC), maintaining a “Buy” recommendation while lowering the target from $6.00 to $4.00. The market response to this target adjustment was notable, with NextCure, Inc. (NASDAQ:NXTC) stock price decreasing by -0.2800 (-19.3103%).

You may also like to read 12 Solar Energy Stocks Billionaires Are Piling Into and 10 Beaten Down Stocks Billionaires Are Crazy About.

Page 5 of 5